Federal grants to Signablok, Inc.
Signablok, Inc. in Worcester, Massachusetts received $2.0 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Vision Research, with $1.1 million. In fiscal 2025 it was awarded $1.4 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.0 million
- Awards4
- Awarded in FY 2025$1.4 million
- Largest award$1.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $550,868 |
| FY 2024 | 0 | $0 |
| FY 2025 | 3 | $1.4 million |
Programs that fund Signablok, Inc.
| Program | Awards | Amount |
|---|---|---|
| Vision Research | 1 | $1.1 million |
| Cardiovascular Diseases Research | 2 | $730,695 |
| Trans-NIH Research Support | 1 | $155,857 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $2.0 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| First-in-class TREM-1 inhibitors for neovascular retinal diseases - project summary/abstract retinal neovascularization (RNV) is a major cause of vision loss in retinopathy of prematurity (ROP), diabetic retinopathy (DR) and retinal vein occlusion. In the us, about 16,000 of premature infants are af | Vision Research | September 6, 2023 | $1.1 million |
| TREM-1 therapy for the treatment of empyema - project summary/abstract the incidence of empyema is increasing and associated with a mortality rate of 20% in patients older than 65 years. About 30% of patients with advanced empyema have contraindications to surgery, showing an urgent need for novel a | Cardiovascular Diseases Research | September 10, 2025 | $457,954 |
| New mechanism-based TREM-1 therapy for acute respiratory distress syndrome - project summary/abstract every year, 150,000 americans are affected by acute respiratory distress syndrome (ARDS), an inflammatory lung condition that may complicate severe pneumonia (including influenza and COVID-19), trau | Cardiovascular Diseases Research | July 31, 2023 | $272,741 |
| Novel medical countermeasure to mitigate potentially lethal acute radiation syndrome - project summary/abstract despite significant advances, gaps remain in developing treatments that address persistent inflammation that ensue after acute radiation exposure. The long-term objective of the proposed p | Trans-NIH Research Support | September 18, 2025 | $155,857 |
Questions people ask
How much federal grant money does Signablok, Inc. get?
$2.0 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Signablok, Inc. the most?
The Department of Health and Human Services, with $2.0 million in 4 awards.
What is Signablok, Inc.'s largest federal grant?
$1.1 million under Vision Research, with its first action in the period on September 6, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Signablok, Inc.?
Its largest are Vision Research, Cardiovascular Diseases Research and Trans-NIH Research Support.
Other grant recipients in Worcester
- University of Massachusetts Medical School
- Worcester Polytechnic Institute
- Worcester Housing Authority
- Worcester Regional Transit Authority
- City of Worcester
- Veterans Inc
- Family Health Center of Worcester Inc
- Edward M Kennedy Community Health Center, Inc
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts